"Designing Growth Strategies is in our DNA"

Glaucoma Therapeutics Market Size, Share, Trends & COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Prostaglandins Analogs, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), By Disease Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100312

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Glaucoma by Major Countries
    2. Recent Industry Developments - Partnerships, Mergers & Acquisitions
    3. Pipeline Analysis
    4. Reimbursement Scenario by Key Countries
    5. Regulatory Scenario for Key Countries
    6. Impact of COVID-19 Pandemic on Glaucoma Therapeutics Market
  5. Global Glaucoma Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Open Angle Glaucoma
      2. Angle Closure Glaucoma
      3. Others
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. Bets Blockers
      2. Prostaglandin Amalogues
        1. Latanoprost
        2. Bimatoprost
        3. Travoprost
        4. Others
      3. Alpha Adrenergic Agonists
      4. Carbonic Anhydrase Inhibitors
      5. Combination Drugs
      6. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Glaucoma Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Open Angle Glaucoma
      2. Angle Closure Glaucoma
      3. Others
    3. Market Analysis – By Drug Class
      1. Bets Blockers
      2. Prostaglandin Amalogues
        1. Latanoprost
        2. Bimatoprost
        3. Travoprost
        4. Others
      3. Alpha Adrenergic Agonists
      4. Carbonic Anhydrase Inhibitors
      5. Combination Drugs
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Glaucoma Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Open Angle Glaucoma
      2. Angle Closure Glaucoma
      3. Others
    3. Market Analysis – By Drug Class
      1. Bets Blockers
      2. Prostaglandin Amalogues
        1. Latanoprost
        2. Bimatoprost
        3. Travoprost
        4. Others
      3. Alpha Adrenergic Agonists
      4. Carbonic Anhydrase Inhibitors
      5. Combination Drugs
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis – By Country/Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Glaucoma Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Open Angle Glaucoma
      2. Angle Closure Glaucoma
      3. Others
    3. Market Analysis – By Drug Class
      1. Bets Blockers
      2. Prostaglandin Amalogues
        1. Latanoprost
        2. Bimatoprost
        3. Travoprost
        4. Others
      3. Alpha Adrenergic Agonists
      4. Carbonic Anhydrase Inhibitors
      5. Combination Drugs
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis – By Country/Sub-region
      1. India
      2. China
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Glaucoma Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Open Angle Glaucoma
      2. Angle Closure Glaucoma
      3. Others
    3. Market Analysis – By Drug Class
      1. Bets Blockers
      2. Prostaglandin Amalogues
        1. Latanoprost
        2. Bimatoprost
        3. Travoprost
        4. Others
      3. Alpha Adrenergic Agonists
      4. Carbonic Anhydrase Inhibitors
      5. Combination Drugs
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Glaucoma Therapeutics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Open Angle Glaucoma
      2. Angle Closure Glaucoma
      3. Others
    3. Market Analysis – By Drug Class
      1. Bets Blockers
      2. Prostaglandin Amalogues
        1. Latanoprost
        2. Bimatoprost
        3. Travoprost
        4. Others
      3. Alpha Adrenergic Agonists
      4. Carbonic Anhydrase Inhibitors
      5. Combination Drugs
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products , SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Merck & Co., Inc.
        1. Overview,
        2. Products ,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Pfizer, Inc.
        1. Overview,
        2. Products ,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Novartis AG
        1. Overview,
        2. Products ,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Allergan plc (part of AbbVie Inc.)
        1. Overview,
        2. Products ,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Bausch & Lomb Incorporated
        1. Overview,
        2. Products ,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Teva Pharmaceutical Industry
        1. Overview,
        2. Products ,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Aerie Pharmaceuticals Inc.
        1. Overview,
        2. Products ,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Inotek Pharmaceuticals
        1. Overview,
        2. Products ,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Glaucoma Therapeutics Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2:  Global Glaucoma Therapeutics Market Value Share (%), by Drug Class, 2019 & 2027

Figure 3:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Beta Blockers, 2016-2027

Figure 4:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Prostaglandins Analogs, 2016-2027

Figure 5:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Alpha Adrenergic Agonists, 2016-2027

Figure 6:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Carbonic Anhydrase Inhibitors, 2016-2027

Figure 7:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Combination Drugs, 2016-2027

Figure 8:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Others, 2016-2027

Figure 9:  Global Glaucoma Therapeutics Market Value Share (%), by Disease Indication, 2019 & 2027

Figure 10:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Open Angle Glaucoma, 2016-2027

Figure 11:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Angle Closure Glaucoma, 2016-2027

Figure 12:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Others, 2016-2027

Figure 13:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by App4, 2016-2027

Figure 14:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by App5, 2016-2027

Figure 15:  Global Glaucoma Therapeutics Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 16:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Hospital Pharmacy, 2016-2027

Figure 17:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Retail Pharmacy, 2016-2027

Figure 18:  Global Glaucoma Therapeutics Market Forecast (US$ Bn), by Online Pharmacy, 2016-2027

Figure 19:  Global Glaucoma Therapeutics Market Value (US$ Bn), by Region, 2019 & 2027

Figure 20:  North America Glaucoma Therapeutics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 21:  North America Glaucoma Therapeutics Market Value Share (%), by Drug Class, 2019

Figure 22:  North America Glaucoma Therapeutics Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 23:  North America Glaucoma Therapeutics Market Value Share (%), by Disease Indication, 2019

Figure 24:  North America Glaucoma Therapeutics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 25:  North America Glaucoma Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 26:  North America Glaucoma Therapeutics Market Value (US$ Bn), By Country, 2019 & 2027

Figure 27:  North America Glaucoma Therapeutics Market Value Share (%), By Country, 2019

Figure 28:  Europe Glaucoma Therapeutics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 29:  Europe Glaucoma Therapeutics Market Value Share (%), by Drug Class, 2019

Figure 30:  Europe Glaucoma Therapeutics Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 31:  Europe Glaucoma Therapeutics Market Value Share (%), by Disease Indication, 2019

Figure 32:  Europe Glaucoma Therapeutics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 33:  Europe Glaucoma Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 34:  Europe Glaucoma Therapeutics Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 35:  Europe Glaucoma Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 36:  Asia Pacific Glaucoma Therapeutics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 37:  Asia Pacific Glaucoma Therapeutics Market Value Share (%), by Drug Class, 2019

Figure 38:  Asia Pacific Glaucoma Therapeutics Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 39:  Asia Pacific Glaucoma Therapeutics Market Value Share (%), by Disease Indication, 2019

Figure 40:  Asia Pacific Glaucoma Therapeutics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 41:  Asia Pacific Glaucoma Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 42:  Asia Pacific Glaucoma Therapeutics Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 43:  Asia Pacific Glaucoma Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 44:  Latin America Glaucoma Therapeutics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 45:  Latin America Glaucoma Therapeutics Market Value Share (%), by Drug Class, 2019

Figure 46:  Latin America Glaucoma Therapeutics Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 47:  Latin America Glaucoma Therapeutics Market Value Share (%), by Disease Indication, 2019

Figure 48:  Latin America Glaucoma Therapeutics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 49:  Latin America Glaucoma Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 50:  Latin America Glaucoma Therapeutics Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 51:  Latin America Glaucoma Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 52:  Middle East & Africa Glaucoma Therapeutics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 53:  Middle East & Africa Glaucoma Therapeutics Market Value Share (%), by Drug Class, 2019

Figure 54:  Middle East & Africa Glaucoma Therapeutics Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 55:  Middle East & Africa Glaucoma Therapeutics Market Value Share (%), by Disease Indication, 2019

Figure 56:  Middle East & Africa Glaucoma Therapeutics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 57:  Middle East & Africa Glaucoma Therapeutics Market Value Share (%), by Distribution Channel, 2019

Figure 58:  Middle East & Africa Glaucoma Therapeutics Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 59:  Middle East & Africa Glaucoma Therapeutics Market Value Share (%), By Country/ Sub-region, 2019

Figure 60:  Global Glaucoma Therapeutics Market Share (%), By Company, 2019

Table 1:  Global Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016–2027

Table 2:  Global Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Prostaglandins Analogs, 2016–2027

Table 3:  Global Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016–2027

Table 4:  Global Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 5:  Global Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 6:  North America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 7:  North America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Prostaglandins Analogs, 2016–2027

Table 8:  North America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 9:  North America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 10:  North America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 11:  Europe Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 12:  Europe Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Prostaglandins Analogs, 2016–2027

Table 13:  Europe Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 14:  Europe Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 15:  Europe Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Asia Pacific Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 17:  Asia Pacific Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Prostaglandins Analogs, 2016–2027

Table 18:  Asia Pacific Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 19:  Asia Pacific Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 20:  Asia Pacific Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Latin America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 22:  Latin America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Prostaglandins Analogs, 2016–2027

Table 23:  Latin America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 24:  Latin America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 25:  Latin America Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 26:  Middle East & Africa Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 27:  Middle East & Africa Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Prostaglandins Analogs, 2016–2027

Table 28:  Middle East & Africa Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 29:  Middle East & Africa Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 30:  Middle East & Africa Glaucoma Therapeutics Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Glaucoma Therapeutics Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase